Allergen immunotherapy reduces symptoms and steroid use in refractory allergic eye disease
Allergen-specific immunotherapy (AIT) was associated with improved symptom control and reduced steroid use in patients with refractory allergic eye disease (AED), according to a study. The retrospective study evaluated 805 patients with AED, including 121 who were classified as having refractory disease due to persistent exacerbations despite treatment. Following allergen testing, 52 patients began AIT... ...